Our View on 2022: Pharm Exec’s Annual Industry Outlook

Supply chain issues, psychedelic medicines, immunotherapies, social engagement, telemedicine, access barriers, corporate branding, and the rise of Chinese biotech are industry topics that deserve a closer look as we head into the future.

Follow the links below to read about each trend:

Logistics - Julian Upton

Psychedelics - Elaine Quilici

Immunotherapies - Elaine Quilici

Social Influence - Fran Pollaro

Patient Engagement - Andy Studna

Health Plan Burdens - Lisa Henderson

Corporate Branding - Fran Pollaro

Chinese Biotech - Julian Upton

Articles in this issue

almost 4 years ago

Article

Keeping Tabs on Quality: The Rise of Digital

almost 4 years ago

Article

China Invests in Building Biotech

almost 4 years ago

Article

Branding Takes on a New Look

almost 4 years ago

Article

Addressing Access Burdens

almost 4 years ago

Article

Meeting the Patient—Virtually

almost 4 years ago

Article

The Age of Influence

almost 4 years ago

Article

Boosting Immunotherapies

almost 4 years ago

Article

Pharma’s Psychedelic Experience

almost 4 years ago

Article

Supply Chain Procurement

almost 4 years ago

Article

Breaking New Ground in Biopharma

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!